toggle mobile menu Menu
toggle search menu

Site Navigation



Blood and Marrow Transplant


Autologous Stem Cell Transplant

Blood and Marrow Transplants, Close to Home

The Blood and Marrow Transplant (BMT) and Hematologic Malignancies program at St. Luke’s Cancer Institute is the first and only one of its kind in Idaho. Our patients receive the region’s most advanced therapies, with the benefit of care close to home.

Studies show that patient outcomes in community transplant programs, such as St. Luke’s Cancer Institute - Center for Blood Cancer Therapy, are equal to those at academic medical centers. Moreover, our patients tell us that their quality of life is better because they’re able to stay close to home and family. We are committed to working with patients and physicians throughout every stage of the transplant process, and to returning patients home as soon as possible.


Allogeneic Stem Cell Transplant

BMT Program Details

We offer you:

  • A highly trained multidisciplinary team of care providers, including specially trained physicians, nurses, social workers, dietitians, and others
  • An on-site, full-service BMT lab that performs the collection, cryopreservation, and storage of all stem cell products
  • The advantages of participation in national clinical trials and cooperation with regional academic and research centers
  • The benefits of a facility accredited by the Foundation for the Accreditation of Cellular Therapy (FACT), a national non-profit organization that promotes high-quality patient care and quality laboratory performance.

Blog Post

St. Luke’s to open new clinic space dedicated to providing innovative CAR T-cell therapy to patients with blood cancers

Procedure Types

St. Luke's Cancer Institute performs autologous transplants (using the patient’s own stem cells), syngeneic transplants (using cells from an identical twin), and allogeneic transplants (using cells from a matched donor). We also offer chimeric antigen receptor (CAR) T-cell therapy, in which a patient's own T cells are extracted and changed in a lab, the re-infused, enabling the T cells to attack the patient's cancer cells.

Like other recognized centers around the country, our team uses mobilized peripheral blood stem cells in the transplant process (PBSCT). Our facility is a National Marrow Donor Program (NMDP) apheresis center.

Who is a candidate for BMT at St. Luke’s Cancer Institute?

When referred by their oncologist, we treat adult and pediatric patients. 

  • Autologous transplants for adult patients: lymphomas and Hodgkin’s disease, multiple myeloma, and some testicular cancers
  • Autologous transplants for pediatric patients: neuroblastoma, lymphomas, Hodgkin’s disease, medulloblastoma, and germ cell tumors 
  • Allogeneic transplants for adult patients: acute leukemia, myelodysplastic syndrome, myelofibrosis, certain lymphomas, and other bone marrow cancers
  • Chimeric antigen receptor (CAR) T-cell therapy: types of non-Hodgkin’s lymphoma, multiple myeloma and acute lymphoblastic leukemia
For more information about referral to our program, call (208) 381-2711 or toll free 1-800-845-4624.

Additional Blood and Marrow Transplant Resources

Support Groups

  • showing 1 of 1
  • An ongoing support program for people with cancer and their loved ones. Share your challenges and discuss topics that influence health and well-being.

Articles & Resources

  • showing 4 of 4